Entacapone

CAS 130929-57-6 12 current records 7 historicalSmall Molecule

Who holds supplier records for Entacapone? 12 organisations hold a current record for Entacapone: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), Finland (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Entacapone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/entacapone

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 12 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Entacapone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Entacapone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Entacapone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2026-076 - Rev 01
Entacapone, Form-A, process-II
Jul 2026—
HEC PHARM GMBH BerlinDE
CEP 2013-127 - Rev 04
Entacapone
Apr 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2021-051 - Rev 01
Entacapone, 1313
Jan 2026—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2010-337 - Rev 04
Entacapone
Dec 2025—
FERMION OY EspooFI
CEP 2021-156 - Rev 01
Entacapone
Oct 2025Inspected Feb 2026
Finland
HETERO LABS LIMITED HyderabadIN
CEP 2012-314 - Rev 01
Entacapone, Form-A
Mar 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2022-405 - Rev 00
Entacapone
Jul 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2010-325 - Rev 03
Entacapone
Dec 2023—
PIRAMAL PHARMA LIMITED Digwal VillageIN
R1-CEP 2015-051 - Rev 01
Entacapone
Jan 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Entacapone are no longer active. These show a past filing, not current supply.

Show all 7 historical records

Overview

Entacapone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL953).

Chemical identity

IUPAC name
(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide
Canonical SMILES
CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N
InChIKey
JRURYQJSLYLRLN-BJMVGYQFSA-N
Synonyms
Comtan, Comtess, Entacapona, Entacapone, Entacapone component of corbilta, Entacapone component of levodopa/carbidopa/ orion, Entacapone component of stalevo, Entacapone orion, Entacapone teva, OR-611, Entacaponum, (E)-Entacapone

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Catechol-O-Methyltransferase Inhibitor
Mechanism of action
Catechol O-Methyltransferase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Entacapone?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Entacapone: COHANCE LIFESCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), FERMION OY (Finland), Hetero Labs Limited (India), Macleods Pharmaceuticals Ltd. (India), Neuland Laboratories Limited (India), Piramal Pharma Limited (India) and HEC PHARM CO (China), and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Entacapone Drug Master Files are active?

COHANCE LIFESCIENCES LTD (DMF 33330, 23937), APITORIA PHARMA PRIVATE LTD (DMF 24188), FERMION OY (DMF 12444), Hetero Labs Limited (DMF 26501), Macleods Pharmaceuticals Ltd. (DMF 25410), Neuland Laboratories Limited (DMF 21526), Piramal Pharma Limited (DMF 29010) and HEC PHARM CO (DMF 27109) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Entacapone records mean?

7 organisations have only inactive Type II DMFs for Entacapone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Entacapone have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Entacapone on the EDQM register, including NEULAND LABORATORIES LIMITED Hyderabad (IN), HEC PHARM GMBH Berlin (DE), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), COHANCE LIFESCIENCES LIMITED Mumbai (IN), FERMION OY Espoo (FI) and HETERO LABS LIMITED Hyderabad (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Entacapone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Entacapone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.